
Conference Co-Chairs
William J. Martone, M.D.
Senior Executive Director
National Foundation for Infectious Diseases
Bethesda, Maryland
Peter L. Nara, D.V.M., Ph.D.
Chief Executive Officer for Research and Development
Biological Mimetics, Inc.
Frederick, Maryland
and
President
International Society for Vaccines
Manassas, Virginia
N. Regina Rabinovich, M.D.
Chief, Clinical Studies Section
Clinical and Regulatory Affairs Branch
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, Maryland
Bruce G. Weniger, M.D.
Assistant Chief for Vaccine Development
Vaccine Safety and Development Activity
National Immunization Program
Centers for Disease Control and Prevention
Atlanta, Georgia
Scientific Program Committee
Robert F. Breiman, M.D.
Director, National Vaccine Program Office
Centers for Disease Control and Prevention
Atlanta, Georgia
Richard J. Duma, M.D., Ph.D.
Director of Infectious Diseases
Halifax Medical Center
Daytona Beach, Florida
M. Carolyn Hardegree, M.D.
Director, Office of Vaccine Research and Review
U.S. Food and Drug Administration
Rockville, Maryland
Colonel Charles H. Hoke, Jr., M.D., M.C.
Director, Military Infectious Disease Research Program
U.S. Army Medical Research and Materiel Command
Fort Detrick, Maryland
David S. Krause, M.D.
Vice President and Director
Clinical Research & Development and Medical Affairs (U.S.)
SmithKline Beecham Biologicals
Collegeville, Pennsylvania
Myron M. Levine, M.D., D.T.P.H.
Professor and Director, Center for Vaccine Development
University of Maryland
Baltimore, Maryland
Brian W.J. Mahy, Ph.D., Sc.D.
Director, Division of Viral and Rickettsial Diseases
National Center for Infectious Diseases
Centers for Disease Control and Prevention
Atlanta, Georgia
William J. Martone, M.D.
Conference Co-Chair
Peter L. Nara, D.V.M., Ph.D.
Conference Co-Chair
Peter R. Paradiso, Ph.D.
Vice President, Scientific Affairs and Research Strategy
Wyeth-Lederle Vaccines and Pediatrics
West Henrietta, New York
Gregory A. Poland, M.D.
Chair, Mayo Vaccine Research Group
Mayo Clinic and Foundation
Rochester, Minnesota
N. Regina Rabinovich, M.D.
Conference Co-Chair
Philip K. Russell, M.D.
Albert B. Sabin Vaccine Institute, Inc. at Georgetown University
Washington, D.C.
Howard R. Six, M.D.
Vice President, Research & Development
Pasteur Mérieux Connaught
Swiftwater, Pennsylvania
Thomas M. Vernon, M.D.
Executive Director, Medical, Scientific, and Public Health Affairs
Merck Vaccine Division
West Point, Pennsylvania
Bruce G. Weniger, M.D.
Conference Co-Chair
Executive Staff Members
Joyce A. Goff
Health Education Specialist
National Immunization Program
Centers for Disease Control and Prevention
Atlanta, Georgia
Robert C. LaGasse
Executive Director
International Society for Vaccines
Manassas, Virginia
Terry M. LaMotte
Special Projects Coordinator
National Foundation for Infectious Diseases
Bethesda, Maryland
Len Novick
Executive Director
National Foundation for Infectious Diseases
Bethesda, Maryland
Invited Presenters and Moderators
Speakers and Presentations Subject to Change
Glenn Austin
Product Development
Program for Appropriate Technology in Health (PATH)
Seattle, Washington
Carol Baker, M.D.
Professor of Pediatrics, Microbiology, and Immunology
Head, Section of Infectious Diseases
Baylor College of Medicine
Houston, Texas
Robert Belshe, M.D.
Director of Infectious Diseases
Department of Medicine
St. Louis University School of Medicine
St. Louis, Missouri
Bradley S. Bender, M.D.
Professor of Medicine
University of Florida
Gainesville Veterans Affairs Medical Center
Gainesville, Florida
Steve Black, M.D.
Co-Director
Kaiser Permanente Vaccine Study Center
Oakland, California
Robert F. Breiman, M.D.
Member, Scientific Program Committee
Michael J. Caulfield, Ph.D.
Research Fellow
Department of Virus and Cell Biology
Merck Research Laboratories
West Point, Pennsylvania
Ranjit Kumar Chandra, M.D.
University Research Professor
Director of Immunology
Memorial University of Newfoundland
St. John's, Newfoundland, Canada
John D. Clemens, M.D.
Chief, Epidemiology Branch
Division of Epidemiology, Statistics, and Prevention Research
National Institute of Child Health and Human Development
National Institutes of Health
Bethesda, Maryland
Mary Lou Clements-Mann, M.D.
Professor, Departments of International Health, Molecular Microbiology and Immunolgy, and Medicine
Center for Immunization Research
School of Hygiene and Public Health
The Johns Hopkins University
Baltimore, Maryland
Mark E. Cook, Ph.D.
Professor, Department of Animal Sciences
University of Wisconsin at Madison
Madison, Wisconsin
Richard J. Duma, M.D., Ph.D.
Member, Scientific Program Committee
Nicolas Glaichenhaus, Ph.D.
Professor, Institut de Pharmacologie Moleculaire et Cellulaire
Université de Nice-Sophia Antipolis
Principal Investigator
Centre National de la Recherche Scientifique
Valbonne, France
W. Paul Glezen, M.D.
Professor and Head, Preventive Medicine Section
Department of Microbiology and Immunology and Pediatrics
Baylor College of Medicine
Houston, Texas
Scott A. Halperin, M.D.
Professor of Pediatrics
Department of Pediatrics
Dalhousie University
IWK Grace Health Center
Halifax, Nova Scotia, Canada
Margaret J. Hosie, Ph.D.
Postdoctoral Research Fellow
Department of Veterinary Pathology
University of Glasgow Veterinary School
Glasgow, Scotland, United Kingdom
Richard A. Insel, M.D.
Professor of Pediatrics, Microbiology, and Immunology
Department of Pediatrics
Director, Strong Children's Research Center
University of Rochester School of Medicine
Rochester, New York
David S. Krause, M.D.
Member, Scientific Program Committee
Myron M. Levine, M.D., D.T.P.H.
Member, Scientific Program Committee
Pamela M. McInnes, D.D.S.
Chief, Respiratory Diseases Branch
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, Maryland
Karen Midthun, M.D.
Chief, Vaccine Clinical Trials Branch
Division of Vaccines and Related Products Applications
Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
Rockville, Maryland
James E. Nagel, M.D.
Staff Scientist
Intramural Research Program
Laboratory of Immunology
Gerontology Research Center
National Institute on Aging
National Institutes of Health
Baltimore, Maryland
Peter L. Nara, D.V.M., Ph.D.
Conference Co-Chair
Mark J. Newman, Ph.D.
Vice President, Research and Development
Vaxcel, Inc.
Norcross, Georgia
Peter R. Paradiso, Ph.D.
Member, Scientific Program Committee
Don A. Rowley, M.D.
Professor Emeritus
Department of Pathology
University of Chicago
Chicago, Illinois
Hans Schreiber, M.D., Ph.D.
Professor, Department of Pathology
University of Chicago
Chicago, Illinois
George R. Siber, M.D.
Vice President and Chief Scientific Officer
Wyeth-Lederle Vaccines and Pediatrics
Pearl River, New York
Carol O. Tacket, M.D.
Chief, Adult Clinical Studies Section
Center for Vaccine Development
Professor of Medicine
University of Maryland School of Medicine
Baltimore, Maryland
D.B. Thomas, D.Phil.
Senior Scientist
Division of Virology
National Institute for Medical Research
London, England, United Kingdom
M.H.V. Van Regenmortel, Ph.D.
Research Director
Immunochimie des Peptides et des Virus
Institut de Biologie Moléculaire et Cellulaire
Centre National de la Recherche Scientifique
Strasbourg, France
Frederick R. Vogel, Ph.D.
Senior Scientist, Vaccine and Preventive Research Program
Division of AIDS
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, Maryland
Bruce G. Weniger, M.D.
Conference Co-Chair
The members of the Scientific Program Committee thank the co-sponsoring organizations for the vision and initiative that made this conference possible, and invite the vaccine community to contribute their data and experience in making it a success worth repeating.
|